On April 8, 2026 Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company utilizing its novel proprietary ARCUS platform to develop in vivo gene editing therapies for high unmet need diseases, reported the Company will participate in the 25th Annual Needham Virtual Healthcare Conference being held April 13-16, 2026.
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
25th Annual Needham Virtual Healthcare Conference
Format: Virtual Corporate presentation
Date/Time: Tuesday, April 14, 2026 at 9:30am ET
Webcast Link: Precision BioSciences Virtual Presentation Link
If you are interested in meeting with the Precision team during the conference, please reach out to your Needham representative.
A replay of the presentation will be available on the Company’s website in the Investors section under Events and Presentations following the event.
(Press release, Precision Biosciences, APR 8, 2026, View Source [SID1234664241])